{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:17:33Z","timestamp":1793038653394,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The prevalence of heart failure with preserved ejection fraction (HFpEF) is increasing, while treatment options are inadequate. Hypertension and obesity-related metabolic dysfunction contribute to HFpEF. Nitro-oleic acid (NO<jats:sub>2<\/jats:sub>-OA) impacts metabolic syndromes by improving glucose tolerance and adipocyte function. Here we show that treatment with NO<jats:sub>2<\/jats:sub>-OA ameliorates diastolic dysfunction and heart failure symptoms in a HFpEF mouse model induced by high-fat diet and inhibition of the endothelial nitric oxide synthase. Proteomic analysis of left ventricular tissue reveals that one-third of identified proteins, predominantly mitochondrial, are upregulated in hearts of NO<jats:sub>2<\/jats:sub>-OA-treated HFpEF mice compared to na\u00efve and vehicle-treated HFpEF mice. Increased mitochondrial mass and numbers, and enhanced mitochondrial respiration are linked with this response, as assessed by transmission electron microscopy and high-resolution respirometry. Activation of the 5\u2019-adenosine-monophosphate-activated-protein-kinase (AMPK) signaling pathway mediates the enhancement of mitochondrial dynamics in hearts of NO<jats:sub>2<\/jats:sub>-OA-treated HFpEF mice. These findings suggest that targeting mitochondrial function with NO<jats:sub>2<\/jats:sub>-OA may represent a promising therapeutic strategy for HFpEF.<\/jats:p>","DOI":"10.1038\/s41467-025-59192-5","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T11:55:55Z","timestamp":1745668555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Nitro-oleic acid enhances mitochondrial metabolism and ameliorates heart failure with preserved ejection fraction in mice"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8519-0661","authenticated-orcid":false,"given":"Marion","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8496-2853","authenticated-orcid":false,"given":"Cornelius","family":"Welke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3258-8621","authenticated-orcid":false,"given":"Tibor","family":"Maske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Patschkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elfi","family":"Donhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Heinen-Weiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3784-6124","authenticated-orcid":false,"given":"Felix-Levin","family":"Hormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3779-8071","authenticated-orcid":false,"given":"Sven","family":"Heiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina Johanna","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa Andrea","family":"Lengenfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Landwehrjohann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa Theres","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5777-3715","authenticated-orcid":false,"given":"Bernd","family":"Stratmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9183-0052","authenticated-orcid":false,"given":"Jurek","family":"Hense","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"L\u00fcdtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1572-9235","authenticated-orcid":false,"given":"Martina","family":"D\u00fcfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tolstik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Dierks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5747-2207","authenticated-orcid":false,"given":"Kristina","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8865-2895","authenticated-orcid":false,"given":"Tamino","family":"Huxohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Christian","family":"Reil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9192-7674","authenticated-orcid":false,"given":"Vasco","family":"Sequeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9526-695X","authenticated-orcid":false,"given":"Francisco Jose","family":"Schopfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-8369","authenticated-orcid":false,"given":"Bruce A.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5385-6839","authenticated-orcid":false,"given":"Volker","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Schlomann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1118-4082","authenticated-orcid":false,"given":"Anna","family":"Klinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"key":"59192_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/ejhf.1741","volume":"22","author":"B Pieske","year":"2020","unstructured":"Pieske, B. et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur. J. Heart Fail 22, 391\u2013412 (2020).","journal-title":"Eur. J. Heart Fail"},{"key":"59192_CR2","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1093\/cvr\/cvac179","volume":"118","author":"AE Peters","year":"2023","unstructured":"Peters, A. E. et al. Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions. Cardiovasc. Res. 118, 3403\u20133415 (2023).","journal-title":"Cardiovasc. Res."},{"key":"59192_CR3","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/ejhf.2894","volume":"25","author":"SD Anker","year":"2023","unstructured":"Anker, S. D. et al. Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension. Eur. J. Heart Fail 25, 936\u2013955 (2023).","journal-title":"Eur. J. Heart Fail"},{"key":"59192_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jchf.2019.09.009","volume":"8","author":"JB Cohen","year":"2020","unstructured":"Cohen, J. B. et al. Clinical Phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to Spironolactone. JACC Heart Fail. 8, 172\u2013184 (2020).","journal-title":"JACC Heart Fail."},{"key":"59192_CR5","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker, S. D. et al. Empagliflozin in heart failure with a preserved ejection fraction. N. Engl. J. Med. 385, 1451\u20131461 (2021).","journal-title":"N. Engl. J. Med."},{"key":"59192_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad192","author":"N Marx","year":"2023","unstructured":"Marx, N. et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur. Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehad192 (2023).","journal-title":"Eur. Heart J."},{"key":"59192_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bbalip.2009.09.015","volume":"1801","author":"JA Chavez","year":"2010","unstructured":"Chavez, J. A. & Summers, S. A. Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms. Biochim. Biophys. Acta 1801, 252\u2013265 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"59192_CR8","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1042\/CS20210127","volume":"135","author":"J Leggat","year":"2021","unstructured":"Leggat, J., Bidault, G. & Vidal-Puig, A. Lipotoxicity: a driver of heart failure with preserved ejection fraction? Clin. Sci. 135, 2265\u20132283 (2021).","journal-title":"Clin. Sci."},{"key":"59192_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cmet.2012.04.006","volume":"15","author":"IJ Goldberg","year":"2012","unstructured":"Goldberg, I. J., Trent, C. M. & Schulze, P. C. Lipid metabolism and toxicity in the heart. Cell Metab. 15, 805\u2013812 (2012).","journal-title":"Cell Metab."},{"key":"59192_CR10","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1093\/cvr\/cvac166","volume":"118","author":"F Capone","year":"2023","unstructured":"Capone, F. et al. Cardiac metabolism in HFpEF: from fuel to signalling. Cardiovasc. Res. 118, 3556\u20133575 (2023).","journal-title":"Cardiovasc. Res."},{"key":"59192_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.molmet.2014.11.004","volume":"4","author":"M Kahle","year":"2015","unstructured":"Kahle, M. et al. High fat diet-induced modifications in membrane lipid and mitochondrial-membrane protein signatures precede the development of hepatic insulin resistance in mice. Mol. Metab. 4, 39\u201350 (2015).","journal-title":"Mol. Metab."},{"key":"59192_CR12","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1194\/jlr.M001230","volume":"51","author":"R Harmancey","year":"2010","unstructured":"Harmancey, R., Wilson, C. R., Wright, N. R. & Taegtmeyer, H. Western diet changes cardiac acyl-CoA composition in obese rats: a potential role for hepatic lipogenesis. J. Lipid Res. 51, 1380\u20131393 (2010).","journal-title":"J. Lipid Res."},{"key":"59192_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.freeradbiomed.2015.07.149","volume":"89","author":"M Delmastro-Greenwood","year":"2015","unstructured":"Delmastro-Greenwood, M. et al. Nitrite and nitrate-dependent generation of anti-inflammatory fatty acid nitroalkenes. Free Radic. Biol. Med. 89, 333\u2013341 (2015).","journal-title":"Free Radic. Biol. Med."},{"key":"59192_CR14","doi-asserted-by":"crossref","unstructured":"Villacorta, L., Gao, Z., Schopfer, F. J., Freeman, B. A. & Chen, Y. E. Nitro-fatty acids in cardiovascular regulation and diseases: characteristics and molecular mechanisms. Front. Biosci. 21, 873\u2013889 (2016).","DOI":"10.2741\/4425"},{"key":"59192_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/cts.12672","volume":"12","author":"RM Garner","year":"2019","unstructured":"Garner, R. M., Mould, D. R., Chieffo, C. & Jorkasky, D. K. Pharmacokinetic and pharmacodynamic effects of oral CXA-10, a nitro fatty acid, after single and multiple ascending doses in healthy and obese subjects. Clin. Transl. Sci. 12, 667\u2013676 (2019).","journal-title":"Clin. Transl. Sci."},{"key":"59192_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1194\/jlr.M088815","volume":"60","author":"M Fazzari","year":"2019","unstructured":"Fazzari, M. et al. Electrophilic fatty acid nitroalkenes are systemically transported and distributed upon esterification to complex lipids. J. Lipid Res. 60, 388\u2013399 (2019).","journal-title":"J. Lipid Res."},{"key":"59192_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep39900","volume":"7","author":"SR Salvatore","year":"2017","unstructured":"Salvatore, S. R., Vitturi, D. A., Fazzari, M., Jorkasky, D. K. & Schopfer, F. J. Evaluation of 10-Nitro Oleic acid bio-elimination in rats and humans. Sci. Rep. 7, 39900 (2017).","journal-title":"Sci. Rep."},{"key":"59192_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.freeradbiomed.2020.10.305","volume":"162","author":"SR Salvatore","year":"2021","unstructured":"Salvatore, S. R., Rowart, P. & Schopfer, F. J. Mass spectrometry-based study defines the human urine nitrolipidome. Free Radic. Biol. Med. 162, 327\u2013337 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"59192_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102941","volume":"68","author":"FA Chowdhury","year":"2023","unstructured":"Chowdhury, F. A. et al. Fatty acid nitroalkenes - Multi-target agents for the treatment of sickle cell disease. Redox Biol. 68, 102941 (2023).","journal-title":"Redox Biol."},{"key":"59192_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20460-8","volume":"8","author":"NKH Khoo","year":"2018","unstructured":"Khoo, N. K. H., Li, L., Salvatore, S. R., Schopfer, F. J. & Freeman, B. A. Electrophilic fatty acid nitroalkenes regulate Nrf2 and NF-\u03baB signaling:A medicinal chemistry investigation of structure-function relationships. Sci. Rep. 8, 2295 (2018).","journal-title":"Sci. Rep."},{"key":"59192_CR21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/cvr\/cvt341","volume":"101","author":"EE Kelley","year":"2014","unstructured":"Kelley, E. E. et al. Fatty acid nitroalkenes ameliorate glucose intolerance and pulmonary hypertension in high-fat diet-induced obesity. Cardiovasc. Res. 101, 352\u2013363 (2014).","journal-title":"Cardiovasc. Res."},{"key":"59192_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101132","volume":"22","author":"NKH Khoo","year":"2019","unstructured":"Khoo, N. K. H. et al. Electrophilic nitro-oleic acid reverses obesity-induced hepatic steatosis. Redox Biol. 22, 101132 (2019).","journal-title":"Redox Biol."},{"key":"59192_CR23","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1073\/pnas.0408384102","volume":"102","author":"FJ Schopfer","year":"2005","unstructured":"Schopfer, F. J. et al. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. Proc. Natl Acad. Sci. USA 102, 2340\u20132345 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59192_CR24","doi-asserted-by":"publisher","first-page":"12321","DOI":"10.1074\/jbc.M109.091512","volume":"285","author":"FJ Schopfer","year":"2010","unstructured":"Schopfer, F. J. et al. Covalent peroxisome proliferator-activated receptor \u03b3 adduction by nitro-fatty acids: Selective ligand activity and anti-diabetic signaling actions. J. Biol. Chem. 285, 12321\u201312333 (2010).","journal-title":"J. Biol. Chem."},{"key":"59192_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","volume":"568","author":"GG Schiattarella","year":"2019","unstructured":"Schiattarella, G. G. et al. Nitrosative stress drives heart failure with preserved ejection fraction. Nature 568, 351\u2013356 (2019).","journal-title":"Nature"},{"key":"59192_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21931-9","volume":"12","author":"GG Schiattarella","year":"2021","unstructured":"Schiattarella, G. G. et al. Xbp1s-FoxO1 axis governs lipid accumulation and contractile performance in heart failure with preserved ejection fraction. Nat. Commun. 12, 1684 (2021).","journal-title":"Nat. Commun."},{"key":"59192_CR27","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1161\/CIRCRESAHA.120.317046","volume":"128","author":"D Tong","year":"2021","unstructured":"Tong, D. et al. NAD(+) Repletion reverses heart failure with preserved ejection fraction. Circ. Res. 128, 1629\u20131641 (2021).","journal-title":"Circ. Res"},{"key":"59192_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.121.058301","volume":"146","author":"D Tong","year":"2022","unstructured":"Tong, D. et al. Impaired AMP-activated protein kinase signaling in heart failure with preserved ejection fraction-associated atrial fibrillation. Circulation 146, 73\u201376 (2022).","journal-title":"Circulation"},{"key":"59192_CR29","doi-asserted-by":"publisher","first-page":"D1541","DOI":"10.1093\/nar\/gkaa1011","volume":"49","author":"S Rath","year":"2021","unstructured":"Rath, S. et al. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 49, D1541\u2013D1547 (2021).","journal-title":"Nucleic Acids Res."},{"key":"59192_CR30","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.devcel.2008.02.004","volume":"14","author":"M Fulco","year":"2008","unstructured":"Fulco, M. et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev. Cell 14, 661\u2013673 (2008).","journal-title":"Dev. Cell"},{"key":"59192_CR31","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nature07813","volume":"458","author":"C Canto","year":"2009","unstructured":"Canto, C. et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056\u20131060 (2009).","journal-title":"Nature"},{"key":"59192_CR32","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/sj.emboj.7601633","volume":"26","author":"Z Gerhart-Hines","year":"2007","unstructured":"Gerhart-Hines, Z. et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1\/PGC-1alpha. EMBO J. 26, 1913\u20131923 (2007).","journal-title":"EMBO J."},{"key":"59192_CR33","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.celrep.2014.09.055","volume":"9","author":"FM Drawnel","year":"2014","unstructured":"Drawnel, F. M. et al. Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells. Cell Rep. 9, 810\u2013821 (2014).","journal-title":"Cell Rep."},{"key":"59192_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11897-023-00589-y","volume":"20","author":"SM Ng","year":"2023","unstructured":"Ng, S. M., Neubauer, S. & Rider, O. J. Myocardial metabolism in heart failure. Curr. Heart Fail Rep. 20, 63\u201375 (2023).","journal-title":"Curr. Heart Fail Rep."},{"key":"59192_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig, S. & Shaw, R. J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 19, 121\u2013135 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"59192_CR36","doi-asserted-by":"publisher","first-page":"20450","DOI":"10.1074\/jbc.M602814200","volume":"281","author":"C Batthyany","year":"2006","unstructured":"Batthyany, C. et al. Reversible post-translational modification of proteins by nitrated fatty acids in vivo. J. Biol. Chem. 281, 20450\u201320463 (2006).","journal-title":"J. Biol. Chem."},{"key":"59192_CR37","doi-asserted-by":"publisher","first-page":"18355","DOI":"10.1074\/jbc.RA120.014883","volume":"295","author":"M Carre\u00f1o","year":"2020","unstructured":"Carre\u00f1o, M. et al. Nitro-fatty acids as activators of hSIRT6 deacetylase activity. J. Biol. Chem. 295, 18355\u201318366 (2020).","journal-title":"J. Biol. Chem."},{"key":"59192_CR38","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3892\/ijmm.2017.2932","volume":"39","author":"P Li","year":"2017","unstructured":"Li, P., Liu, Y., Burns, N., Zhao, K. S. & Song, R. SIRT1 is required for mitochondrial biogenesis reprogramming in hypoxic human pulmonary arteriolar smooth muscle cells. Int J. Mol. Med. 39, 1127\u20131136 (2017).","journal-title":"Int J. Mol. Med."},{"key":"59192_CR39","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/antiox10030338","volume":"10","author":"B Paramesha","year":"2021","unstructured":"Paramesha, B. et al. Sirt1 and Sirt3 activation improved cardiac function of diabetic rats via modulation of mitochondrial function. Antioxidants 10, 338 (2021).","journal-title":"Antioxidants"},{"key":"59192_CR40","doi-asserted-by":"publisher","first-page":"42464","DOI":"10.1074\/jbc.M504212200","volume":"280","author":"PR Baker","year":"2005","unstructured":"Baker, P. R. et al. Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands. J. Biol. Chem. 280, 42464\u201342475 (2005).","journal-title":"J. Biol. Chem."},{"key":"59192_CR41","doi-asserted-by":"publisher","first-page":"d4169","DOI":"10.1136\/bmj.d4169","volume":"343","author":"R Boussageon","year":"2011","unstructured":"Boussageon, R. et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ 343, d4169 (2011).","journal-title":"BMJ"},{"key":"59192_CR42","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(07)61514-1","volume":"370","author":"RM Lago","year":"2007","unstructured":"Lago, R. M., Singh, P. P. & Nesto, R. W. Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet 370, 1129\u20131136 (2007).","journal-title":"Lancet"},{"key":"59192_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2165\/11587580-000000000-00000","volume":"11","author":"AV Hernandez","year":"2011","unstructured":"Hernandez, A. V., Usmani, A., Rajamanickam, A. & Moheet, A. Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials. Am. J. Cardiovasc. Drugs 11, 115\u2013128 (2011).","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"59192_CR44","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006170","volume":"13","author":"D Miranda-Silva","year":"2020","unstructured":"Miranda-Silva, D. et al. Mitochondrial reversible changes determine diastolic function adaptations during myocardial (reverse) remodeling. Circ. Heart Fail 13, e006170 (2020).","journal-title":"Circ. Heart Fail"},{"key":"59192_CR45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/BJ20112026","volume":"443","author":"L Bultot","year":"2012","unstructured":"Bultot, L. et al. AMP-activated protein kinase phosphorylates and inactivates liver glycogen synthase. Biochem. J. 443, 193\u2013203 (2012).","journal-title":"Biochem. J."},{"key":"59192_CR46","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/CIRCULATIONAHA.119.043319","volume":"142","author":"D Shao","year":"2020","unstructured":"Shao, D. et al. Increasing fatty acid oxidation prevents high-fat diet-induced cardiomyopathy through regulating parkin-mediated mitophagy. Circulation 142, 983\u2013997 (2020).","journal-title":"Circulation"},{"key":"59192_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14418","author":"AA van de Bovenkamp","year":"2023","unstructured":"van de Bovenkamp, A. A. et al. Trimetazidine in heart failure with preserved ejection fraction: a randomized controlled cross-over trial. ESC Heart Fail https:\/\/doi.org\/10.1002\/ehf2.14418 (2023).","journal-title":"ESC Heart Fail"},{"key":"59192_CR48","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1161\/CIRCULATIONAHA.121.054858","volume":"144","author":"MK Burrage","year":"2021","unstructured":"Burrage, M. K. et al. Energetic basis for exercise-induced pulmonary congestion in heart failure with preserved ejection fraction. Circulation 144, 1664\u20131678 (2021).","journal-title":"Circulation"},{"key":"59192_CR49","first-page":"H1030","volume":"269","author":"BL Hamman","year":"1995","unstructured":"Hamman, B. L. et al. Inhibition of the creatine kinase reaction decreases the contractile reserve of isolated rat hearts. Am. J. Physiol. 269, H1030\u2013H1036 (1995).","journal-title":"Am. J. Physiol."},{"key":"59192_CR50","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1161\/hc3901.095933","volume":"104","author":"M Horn","year":"2001","unstructured":"Horn, M., Remkes, H., Str\u00f6mer, H., Dienesch, C. & Neubauer, S. Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction. Circulation 104, 1844\u20131849 (2001).","journal-title":"Circulation"},{"key":"59192_CR51","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1172\/JCI119220","volume":"99","author":"R Tian","year":"1997","unstructured":"Tian, R. et al. Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart. J. Clin. Invest. 99, 745\u2013751 (1997).","journal-title":"J. Clin. Invest."},{"key":"59192_CR52","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1113\/JP270354","volume":"593","author":"V Sequeira","year":"2015","unstructured":"Sequeira, V. et al. Synergistic role of ADP and Ca(2+) in diastolic myocardial stiffness. J. Physiol. 593, 3899\u20133916 (2015).","journal-title":"J. Physiol."},{"key":"59192_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/apha.14124","volume":"240","author":"L Semmler","year":"2024","unstructured":"Semmler, L. et al. Impairment of the adrenergic reserve associated with exercise intolerance in a murine model of heart failure with preserved ejection fraction. Acta Physiol. 240, e14124 (2024).","journal-title":"Acta Physiol."},{"key":"59192_CR54","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1006\/jmcc.2002.2062","volume":"34","author":"JS Ingwall","year":"2002","unstructured":"Ingwall, J. S. Is creatine kinase a target for AMP-activated protein kinase in the heart? J. Mol. Cell Cardiol. 34, 1111\u20131120 (2002).","journal-title":"J. Mol. Cell Cardiol."},{"key":"59192_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12997\/jla.2022.11.1.1","volume":"11","author":"H Saucedo-Orozco","year":"2022","unstructured":"Saucedo-Orozco, H., Voorrips, S. N., Yurista, S. R., de Boer, R. A. & Westenbrink, B. D. SGLT2 Inhibitors and Ketone Metabolism in Heart Failure. J. Lipid Atheroscler. 11, 1\u201319 (2022).","journal-title":"J. Lipid Atheroscler."},{"key":"59192_CR56","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-020-01100-w","volume":"19","author":"A Halabi","year":"2020","unstructured":"Halabi, A., Sen, J., Huynh, Q. & Marwick, T. H. Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysis. Cardiovasc. Diabetol. 19, 124 (2020).","journal-title":"Cardiovasc. Diabetol."},{"key":"59192_CR57","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1161\/CIRCRESAHA.110.218404","volume":"107","author":"J Zhang","year":"2010","unstructured":"Zhang, J. et al. Nitro-oleic acid inhibits angiotensin II-induced hypertension. Circ. Res. 107, 540\u2013548 (2010).","journal-title":"Circ. Res."},{"key":"59192_CR58","doi-asserted-by":"publisher","first-page":"8167","DOI":"10.1073\/pnas.1402965111","volume":"111","author":"RL Charles","year":"2014","unstructured":"Charles, R. L. et al. Protection from hypertension in mice by the Mediterranean diet is mediated by nitro fatty acid inhibition of soluble epoxide hydrolase. Proc. Natl Acad. Sci. USA 111, 8167\u20138172 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59192_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71870-6","volume":"10","author":"M Mollenhauer","year":"2020","unstructured":"Mollenhauer, M. et al. Nitro-fatty acids suppress ischemic ventricular arrhythmias by preserving calcium homeostasis. Sci. Rep. 10, 15319 (2020).","journal-title":"Sci. Rep."},{"key":"59192_CR60","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/cvr\/cvn323","volume":"82","author":"SM Nadtochiy","year":"2009","unstructured":"Nadtochiy, S. M., Baker, P. R., Freeman, B. A. & Brookes, P. S. Mitochondrial nitroalkene formation and mild uncoupling in ischaemic preconditioning: implications for cardioprotection. Cardiovasc. Res. 82, 333\u2013340 (2009).","journal-title":"Cardiovasc. Res."},{"key":"59192_CR61","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1074\/jbc.M111.298406","volume":"287","author":"SM Nadtochiy","year":"2012","unstructured":"Nadtochiy, S. M. et al. Nitroalkenes confer acute cardioprotection via adenine nucleotide translocase 1. J. Biol. Chem. 287, 3573\u20133580 (2012).","journal-title":"J. Biol. Chem."},{"key":"59192_CR62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306963","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod, M. N. et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2306963 (2023).","journal-title":"N. Engl. J. Med."},{"key":"59192_CR63","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/dom.14990","volume":"25","author":"VR Aroda","year":"2023","unstructured":"Aroda, V. R. et al. Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes. Diab. Obes. Metab. 25, 1385\u20131397 (2023).","journal-title":"Diab. Obes. Metab."},{"key":"59192_CR64","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.niox.2018.06.006","volume":"79","author":"FJ Schopfer","year":"2018","unstructured":"Schopfer, F. J., Vitturi, D. A., Jorkasky, D. K. & Freeman, B. A. Nitro-fatty acids: New drug candidates for chronic inflammatory and fibrotic diseases. Nitric Oxide 79, 31\u201337 (2018).","journal-title":"Nitric Oxide"},{"key":"59192_CR65","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.niox.2024.06.002","volume":"149","author":"DV Chartoumpekis","year":"2024","unstructured":"Chartoumpekis, D. V. et al. Adipocyte-specific Nrf2 deletion negates nitro-oleic acid benefits on glucose tolerance in diet-induced obesity. Nitric Oxide 149, 75\u201384 (2024).","journal-title":"Nitric Oxide"},{"key":"59192_CR66","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/cvr\/cvaa110","volume":"117","author":"S Zacchigna","year":"2021","unstructured":"Zacchigna, S. et al. Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function. Cardiovasc. Res. 117, 43\u201359 (2021).","journal-title":"Cardiovasc. Res."},{"key":"59192_CR67","doi-asserted-by":"publisher","first-page":"H501","DOI":"10.1152\/ajpheart.00138.2005","volume":"289","author":"D Burkhoff","year":"2005","unstructured":"Burkhoff, D., Mirsky, I. & Suga, H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am. J. Physiol. Heart Circ. Physiol. 289, H501\u2013H512 (2005).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"59192_CR68","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1021\/ac026117i","volume":"75","author":"J Rappsilber","year":"2003","unstructured":"Rappsilber, J., Ishihama, Y. & Mann, M. Stop and go extraction tips for matrix-assisted laser desorption\/ionization, nanoelectrospray, and LC\/MS sample pretreatment in proteomics. Anal. Chem. 75, 663\u2013670 (2003).","journal-title":"Anal. Chem."},{"key":"59192_CR69","first-page":"557","volume":"18","author":"M Dilillo","year":"2019","unstructured":"Dilillo, M., de Graaf, E. L., Yadav, A., Belov, M. E. & McDonnell, L. A. Ultraviolet photodissociation of ESI- and MALDI-generated protein ions on a Q-Exactive Mass Spectrometer. J. Proteome Res. 18, 557\u2013564 (2019).","journal-title":"J. Proteome Res."},{"key":"59192_CR70","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731\u2013740 (2016).","journal-title":"Nat. Methods"},{"key":"59192_CR71","doi-asserted-by":"publisher","first-page":"14619","DOI":"10.1111\/jcmm.15773","volume":"24","author":"H Li","year":"2020","unstructured":"Li, H. et al. Optimized Langendorff perfusion system for cardiomyocyte isolation in adult mouse heart. J. Cell Mol. Med. 24, 14619\u201314625 (2020).","journal-title":"J. Cell Mol. Med."},{"key":"59192_CR72","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","volume":"49","author":"V Matyash","year":"2008","unstructured":"Matyash, V., Liebisch, G., Kurzchalia, T. V., Shevchenko, A. & Schwudke, D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 49, 1137\u20131146 (2008).","journal-title":"J. Lipid Res."},{"key":"59192_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33225-9","volume":"13","author":"A Criscuolo","year":"2022","unstructured":"Criscuolo, A. et al. Analytical and computational workflow for in-depth analysis of oxidized complex lipids in blood plasma. Nat. Commun. 13, 6547 (2022).","journal-title":"Nat. Commun."},{"key":"59192_CR74","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1083\/jcb.30.2.424","volume":"30","author":"AM Seligman","year":"1966","unstructured":"Seligman, A. M., Wasserkrug, H. L. & Hanker, J. S. A new staining method (OTO) for enhancing contrast of lipid-containing membranes and droplets in osmium tetroxide-fixed tissue with osmiophilic thiocarbohydrazide(TCH). J. Cell Biol. 30, 424\u2013432 (1966).","journal-title":"J. Cell Biol."},{"key":"59192_CR75","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"59192_CR76","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59192-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59192-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59192-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T13:03:04Z","timestamp":1745672584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59192-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59192"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59192-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"BAF acknowledges an interest in Creegh Pharmaceuticals, Inc., and FJS acknowledges an interest in Creegh Pharmaceuticals, Inc. and Furanica, Inc. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3933"}}